LifeArc Rare Disease Clinical Trials Programme
Supports clinical rare-disease teams with practical trial design and execution.
LifeArc is a UK-registered not-for-profit life science organisation (Charity No. 1015243) founded in 2000 as MRC Technology, which gained major endowment through the 2019 sale of rights to the cancer drug pembrolizumab (Keytruda). Its Rare Disease Clinical Trials Programme is a rolling grant facility open for applications year-round, with proposals reviewed on a continuous basis. The programme fun…
Rolling grants of up to £5 million for clinical-stage rare disease trial projects, with particular encouragement for rare neurodegenerative diseases, rare respiratory conditions, and childhood cancer.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Write proposalGrant Letter of Intent: How to Write an LOI or Letter of Inquiry
Learn what a grant letter of intent is, when funders ask for LOIs or letters of inquiry, what to include, what to avoid, and how funder rules differ.
More from LifeArc
All grants from this funder →LifeArc Early Ventures
🇬🇧LifeArc · United Kingdom
Funds early-stage life science ventures with seed and Series A equity across therapeutics and medical device innovation.
Drug Repurposing Call to Treat Chronic Respiratory Infection
🇬🇧LifeArc · United Kingdom
Funds UK-led consortia repurposing drugs for bronchiectasis and cystic fibrosis.
LifeArc and Action Medical Research Fund
🇬🇧LifeArc · United Kingdom
Co-funds UK translational research turning rare-disease science into treatments.
LifeArc Gene Therapy Innovation Fund
🇬🇧LifeArc · United Kingdom
Funds promising gene therapies for rare conditions through LifeArc's Gene Therapy Innovation Fund.
LifeArc KT Innovation Fellowship
🇬🇧LifeArc · United Kingdom
Supports career fellowship for early career European life scientists entering technology transfer travel expenses only no stipend.
LifeArc Philanthropic Fund
🇬🇧LifeArc · United Kingdom
Funds rare-disease therapeutics, devices and diagnostics from academics and early-stage spinout companies.
Similar grants
Browse the directory →
NEI SBIR Phase II — R&D
🇺🇸NEI · United States
Supports United States. small businesses scaling vision concepts into full development pathways.
NEI STTR Phase II — R&D
🇺🇸NEI · United States
Funds collaborative small-business partnerships to mature vision innovation into market-ready healthcare technologies.
BBSRC Industrial Partnership Awards (IPA) — Always Open
🇬🇧BBSRC · United Kingdom
Supports United Kingdom industry-academia teams through partnership awards for precommercial innovation experiments.
NIH CRP Commercialization Readiness Pilot
🇺🇸NIH SEED · United States
Offers late stage commercialization readiness support through NIH CRP for small firms advancing biomedical health solutions.
Wadhwani Innovation Network — Center of Excellence Research Grants
🇮🇳Wadhwani · India
Funds Indian Center of Excellence teams working on deep technology and bioengineering commercialization.
BBSRC Stand-alone LINK — Always Open
🇬🇧BBSRC · United Kingdom
Supports United Kingdom university and industry teams through LINK grants that share innovation ownership and risk.